6-Mar-2026
EyePoint Pharma Bets Big on DuraVu in Pivotal Push
TipRanks (Fri, 6-Mar 7:27 PM ET)
TipRanks (Fri, 6-Mar 7:30 AM ET)
EyePoint Pharmaceuticals (EYPT) Receives a Buy from Jefferies
TipRanks (Thu, 5-Mar 12:06 PM ET)
Guggenheim Remains a Buy on EyePoint Pharmaceuticals (EYPT)
TipRanks (Thu, 5-Mar 7:17 AM ET)
EyePoint Pharmaceuticals (EYPT) Gets a Buy from RBC Capital
TipRanks (Thu, 5-Mar 7:17 AM ET)
Seeking Alpha News (Wed, 4-Mar 5:12 PM ET)
EyePoint Pharmaceuticals GAAP EPS of -$0.81 misses by $0.08, revenue of $0.62M misses by $0.39M
Seeking Alpha News (Wed, 4-Mar 7:04 AM ET)
Globe Newswire (Wed, 4-Mar 7:00 AM ET)
Here are the major earnings before the open Wednesday
Seeking Alpha News (Tue, 3-Mar 6:00 PM ET)
EyePoint Pharmaceuticals Q4 2025 Earnings Preview
Seeking Alpha News (Tue, 3-Mar 10:31 AM ET)
EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
Eyepoint trades on the NASDAQ stock market under the symbol EYPT.
As of March 6, 2026, EYPT stock price declined to $15.75 with 1,834,271 million shares trading.
EYPT has a beta of 2.03, meaning it tends to be more sensitive to market movements. EYPT has a correlation of 0.20 to the broad based SPY ETF.
EYPT has a market cap of $1.27 billion. This is considered a Small Cap stock.
Last quarter Eyepoint reported $620,000 in Revenue and -$.81 earnings per share. This fell short of revenue expectation by $-199,480 and missed earnings estimates by -$.05.
In the last 3 years, EYPT traded as high as $30.99 and as low as $2.21.
The top ETF exchange traded funds that EYPT belongs to (by Net Assets): VTI, IWM, VXF, IWN, SCHA.
EYPT has outperformed the market in the last year with a price return of +139.4% while the SPY ETF gained +16.6%. However, in the short term, EYPT had mixed performance relative to the market. It has underperformed in the last 3 months, returning -11.2% vs -1.7% return in SPY. But in the last 2 weeks, EYPT shares have fared better than the market returning +7.1% compared to SPY -1.8%.
EYPT support price is $14.89 and resistance is $16.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EYPT shares will trade within this expected range on the day.